Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

Peritoneal Carcinomatosis in T4 Colorectal Cancer: Occurrence and Risk Factors

(2014) H. C. van Santvoort et al.   ANNALS OF SURGICAL ONCOLOGY

Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review

(2014) D A M Sloothaak et al.   BRITISH JOURNAL OF CANCER

Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis

(2014) D.A.M. Sloothaak et al.   EJSO

Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases

(2014) P. Sammartino et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer

(2013) Y.R.B.M. van Gestel et al.   EJSO

Colorectal Cancer Metastases

(2013) Paul H. Sugarbaker   Surgical Oncology Clinics of North America

HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?

(2012) D. Hompes et al.   ANNALS OF ONCOLOGY

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

(2012) J. Segelman et al.   BRITISH JOURNAL OF SURGERY

Current Status of Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Colorectal Cancer

(2012) Thomas Weber et al.   Clinical Colorectal Cancer

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy

(2012) Y.L.B. Klaver et al.   EJSO

Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: Analysis of two centres

(2012) Shigeki Kusamura et al.   JOURNAL OF SURGICAL ONCOLOGY

Early Intervention for Treatment and Prevention of Colorectal Carcinomatosis

(2012) Paul H. Sugarbaker   Surgical Oncology Clinics of North America

Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis

(2011) D Elias et al.   ANNALS OF SURGERY

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

(2011) Jan Franko et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of Intraperitoneal Chemotherapy with Mitomycin C on the Prevention of Peritoneal Recurrence in Colorectal Cancer Patients with Positive Peritoneal Lavage Cytology Findings

(2010) Shingo Noura et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis

(2010) Jan Franko et al.   CANCER

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study

(2010) Valery E. Lemmens et al.   INTERNATIONAL JOURNAL OF CANCER

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY